At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:19 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 15,364,105 shares of INOVIO PHARMACEUTICALS, INC. as of September 30, 2026, representing 14.5% of outstanding common stock. This is a routine passive stake update; the filing does not disclose the prior period's share count for comparison, so the direction of change cannot be determined from the documents provided.
- FMR LLC reported beneficial ownership of 15,364,105 shares of INOVIO common stock as of September 30, 2026.
- The stake represents 14.5% of outstanding shares.
- Fidelity Small Cap Growth Fund held 6,083,134 shares (5.8%) and Fidelity Small Cap Growth K6 Fund held 5,540,883 shares (5.2%) as of the same date.
- The filing is an amendment to Schedule 13G, indicating passive investment intent.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access